1 – 5 of 5
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Mechanisms of Resistance to Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer
2021) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 62(7). p.989-995(
- Contribution to journal › Article
-
Mark
PSA-Targeted Alpha-, Beta-, and Positron-emitting immunotheranostics in murine prostate cancer models and nonhuman primates
(
- Contribution to journal › Article
- 2020
-
Mark
Targeted alpha therapy in a systemic mouse model of prostate cancer - a feasibility study
(
- Contribution to journal › Article
-
Mark
Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy
2020) In Proceedings of the National Academy of Sciences of the United States of America 117(26). p.15172-15181(
- Contribution to journal › Article
- 2018
-
Mark
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer
(
- Contribution to journal › Article